RPTX

News Repare (RPTX) Up 14% as Ovarian Cancer Combo Gets Fast Track Tag

14d ago

SEC filing RPTX Acquired by XenoTherapeutics for $2.20/Share, CVR Issuance

124d ago

News Halper Sadeh LLC Encourages RPTX, THS, RMBI Shareholders to Contact the Firm to Discuss Their Rights

153d ago

News Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million

159d ago

News Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million

160d ago

News Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

160d ago

News $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--RPTX, FRGE, CSGS, FIZN

165d ago

Scanner Unusual volume (z=5.7)

171d ago